Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2008
A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptideLi-Chung Hsu, Syed R Ali, Shauna McGillivray, et al.
Comparative Immunology, Microbiology and Infectious Diseases|May 8, 2012
Activation of rabbit TLR9 by different CpG-ODN optimized for mouse and human TLR9Jin Liu, Congfeng Xu, Yi-Ling Liu, et al.
Cell Death & Disease|September 28, 2021
USP7 facilitates SMAD3 autoregulation to repress cancer progression in p53-deficient lung cancerYu-Ting Huang, An-Chieh Cheng, Hui-Chi Tang, et al.
Blood|January 25, 2005
Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistancePing-Hui Tseng, Ho-Pi Lin, Jiuxiang Zhu, et al.
Oncotarget|June 23, 2014
RFX1-dependent activation of SHP-1 induces autophagy by a novel obatoclax derivative in hepatocellular carcinoma cellsJung-Chen Su, Ping-Hui Tseng, Cheng-Yi Hsu, et al.
Scientific Reports|December 13, 2017
CpG-oligodeoxynucleotides developed for grouper toll-like receptor (TLR) 21s effectively activate mouse and human TLR9s mediated immune responsesDa-Wei Yeh, Chao-Yang Lai, Yi-Ling Liu, et al.
Neoplasia (New York, N.Y.)|July 23, 2014
SC-2001 overcomes STAT3-mediated sorafenib resistance through RFX-1/SHP-1 activation in hepatocellular carcinomaJung-Chen Su, Ping-Hui Tseng, Szu-Hsien Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2008
Analysis of nondegradative protein ubiquitylation with a monoclonal antibody specific for lysine-63-linked polyubiquitinHaopeng Wang, Atsushi Matsuzawa, Scott A Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2010
B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemiaWeizhou Zhang, Arnon P Kater, George F Widhopf, et al.
Molecular Pharmacology|August 5, 2006
Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitorPing-Hui Tseng, Yu-Chieh Wang, Shu-Chuan Weng, et al.
Pageof 4